Bacopa Monnieri for ADHD: Dosage for Children & Adults
Your child has been diagnosed with ADHD. Or you have - as an adult who finally has a name for decades of scattered focus.
Either way, you are probably looking for every option available to you.
Bacopa Monnieri (Brahmi) keeps coming up in that search. It is one of the most studied Ayurvedic herbs for cognitive function, and there is a growing body of clinical research specifically on its use in ADHD.
This guide covers what the research actually says about dosage, what to expect, and what to know before starting - for both children and adults.
One important note before we begin: Bacopa Monnieri is not a treatment for ADHD. It is a herbal supplement with a meaningful research record for cognitive support. Always consult a doctor or paediatrician before using it alongside or instead of prescribed treatment.
What Is ADHD and Why Are So Many Indian Families Dealing With It?
ADHD (Attention Deficit Hyperactivity Disorder) is a neurodevelopmental condition characterised by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning.[1]
In India, the numbers are significant.
A meta-analysis published on PubMed examining ADHD prevalence in Indian children found a pooled prevalence of 63.2 per 1000 children surveyed in school-based settings - roughly 1 in 13 children. [2]
And yet diagnosis rates remain low. Many children with ADHD in India go years without a proper evaluation, labelled instead as lazy, undisciplined, or simply "not trying hard enough."

Why Parents and Adults Are Looking at Bacopa
Prescription stimulant medications remain the standard treatment for ADHD, and they work well for the majority of people.
However, the open-label clinical study on Bacopa in ADHD children conducted in Mumbai noted that standard psychostimulant medications have an average response rate of around 70%, and up to 30% of children either do not respond to these medications or are unable to tolerate side effects such as nausea, insomnia, and weight loss. [3]
This is the gap that parents and adults are looking to address. Not to replace a doctor's advice, but to find additional support that has a clean safety profile and a traditional and clinical basis.
Bacopa Monnieri, known in India as Brahmi, is the herb most studied in this space.
How Does Bacopa Monnieri Work for ADHD Symptoms?
Bacopa's active compounds are called bacosides, primarily bacoside A and bacoside B.
These work through several pathways relevant to ADHD:
Acetylcholine modulation. Bacopa inhibits the enzyme that breaks down acetylcholine, keeping this important neurotransmitter (linked to attention and memory) active for longer in the brain.
Dopamine and serotonin support. The alkaloids in Brahmi, including brahmine and herpestine, influence dopamine and serotonin pathways - the same neurotransmitter systems that ADHD medications target, though by a different mechanism and with less potency.
Cortisol reduction. Bacopa acts as an adaptogen, reducing the stress response. This matters for ADHD because elevated cortisol actively disrupts the prefrontal cortex, the brain's centre for attention, impulse control, and planning.
Antioxidant neuroprotection. Bacosides reduce oxidative stress in brain tissue, protecting neurons from damage and supporting healthy neural signalling over time.
These are not immediate effects. Bacopa works gradually and cumulatively, which is why all clinical studies run for a minimum of 12 weeks.

Bacopa Monnieri Dosage for Children with ADHD
This is the most searched question, and the honest answer is that dosage in children depends on age, weight, and the form of Bacopa being used.
Here is what the research shows.
What the Key Study Found
The most cited clinical study on Bacopa and ADHD in children was conducted at the Centre for Research in Mental Retardation (CREMERE) in Mumbai. Published on PubMed (Dave et al., 2014), it involved 31 children aged 6 to 12 years, all diagnosed with ADHD.[4]
Children received 225mg per day of standardised Bacopa monnieri extract for 6 months.
The results:
- Restlessness reduced in 93% of children
- Self-control improved in 89% of children
- Attention deficit symptoms reduced in 85% of children
- Learning problems reduced in 78% of children
The extract was well-tolerated with no serious adverse effects reported.
An earlier study using a twice-daily dose of 50mg of Bacopa extract standardised to 20% bacosides (equivalent to 100mg total per day) in 36 children with ADHD over 16 weeks also showed significant improvements in logical memory, sentence repetition, and paired associate learning at the 12-week mark, with effects maintained at 16 weeks.
General Dosage Guidance for Children
Based on the available research, general guidance for children (always to be confirmed with a paediatrician) is:
|
Age Group |
Typical Dosage Range |
Form |
|---|---|---|
|
6 to 8 years |
100 to 150mg standardised extract per day |
Liquid drops preferred |
|
9 to 12 years |
150 to 225mg standardised extract per day |
Liquid drops or child-appropriate capsule |
|
13 to 18 years |
225 to 300mg standardised extract per day |
Liquid drops or capsule |
Critical notes:
- Always use a child-specific formulation - adult capsules should not be split and given to children
- Liquid drops are strongly preferred for children: easier to dose accurately, easier to administer, and absorption is better when mixed with warm milk (bacosides are fat-soluble)
- Start at the lower end of the range and increase gradually after 2 to 4 weeks if well tolerated
- Bacopa takes 8 to 12 weeks of consistent daily use before meaningful cognitive benefits become apparent
- Give with food or warm milk, never on an empty stomach

Bacopa Monnieri Dosage for Adults with ADHD
Adult dosage research is more robust and draws from both ADHD-specific trials and broader cognitive function studies.
What Research-Backed Dosage Looks Like
The NCBI StatPearls review of Bacopa monnieri and the broader clinical literature consistently support a dosage range of 300 to 450mg per day of standardised extract for adults, taken in one or two doses with meals.[5]
A 12-week study using 300mg per day of a standardised Bacopa extract in healthy adults demonstrated significant improvements in verbal learning, memory consolidation, and speed of early information processing compared to placebo.
A larger meta-analysis incorporating 9 randomised controlled trials found improved speed of attention and cognition and decreased reaction time across studies.
For ADHD specifically, the standard adult dose used across clinical observation is 300mg per day, taken with food, for a minimum period of 12 weeks before assessing response.
General Dosage Guidance for Adults
|
Situation |
Dosage |
Notes |
|---|---|---|
|
General cognitive support / mild inattention |
300mg/day |
Take with a fat-containing meal for better absorption |
|
Moderate inattention or ADHD (alongside doctor guidance) |
300 to 450mg/day |
Split into two doses if GI discomfort occurs |
|
Maintenance after 12-week course |
300mg/day |
Continue consistently for sustained benefit |
When to expect results:
Most people notice subtle improvements in focus and reduced mental restlessness between 4 to 8 weeks. Memory and information processing improvements tend to become more apparent after the 12-week mark.
Do not assess Bacopa's effectiveness before 8 weeks. Stopping early is the most common reason people conclude it is not working.
How to Take Bacopa: Form and Timing
Best Forms of Bacopa for ADHD Support
Standardised extract (capsules or drops) - the most reliable form. Look for a product stating the percentage of bacosides, ideally 40 to 55%. This ensures you know exactly what dose of active compounds you are consuming.
Liquid drops - best for children and anyone who struggles with capsules. Mixes easily into warm milk or water. The fat in milk also aids absorption of the fat-soluble bacosides.
Raw Brahmi leaves or powder - far less reliable for targeting specific dosage. The bacoside content varies significantly between batches and cannot be standardised. Not recommended if the goal is consistent cognitive support.
Our full guide on how to use Brahmi leaves covers this in more detail.
Timing
- Take with a meal, not on an empty stomach
- Morning is preferred for most people to avoid any interaction with sleep
- If split into two doses, morning and afternoon work well
- Avoid taking late in the evening, as its mild stimulating effect on neurotransmitters could interfere with sleep in sensitive individuals

What to Look for in a Bacopa Supplement for ADHD Support
Not all Bacopa supplements are equal. Here is what to verify before buying:
Standardised extract, not raw herb powder. The label must state the percentage of bacosides (look for 40 to 55%). Without this, you cannot know what dose you are actually taking.
Child-specific formulation for children. This is non-negotiable. A formulation designed for children will have appropriate dosing, child-safe excipients, and a form (usually liquid) that is actually usable.
GMP manufacturing. Good Manufacturing Practice certification means the product has been produced under verified quality control standards.
Transparent labelling. The product should clearly state the amount of extract per serving. Proprietary blends that hide individual ingredient amounts are a red flag when exact dosing matters.
No unnecessary additives. Artificial colours, synthetic preservatives, and unnecessary fillers are not appropriate in a supplement given to children daily.
Important Safety Information and Precautions
Bacopa is generally well-tolerated with a high therapeutic index. But there are specific situations that require caution.
According to the NCBI StatPearls review of Bacopa monnieri, the following interactions and precautions apply[6]:
Thyroid medication. Animal research suggests Bacopa may increase thyroxine (T4) levels. If you or your child takes thyroid medication (levothyroxine or similar), consult a doctor before using Bacopa.
Anticholinergic drugs. Bacopa inhibits acetylcholinesterase, which increases acetylcholine. This can counteract anticholinergic medications and should be discussed with a physician if relevant.
Sedative medications. Do not combine Bacopa with sedatives without medical guidance.
Before surgery. Stop Bacopa at least 2 weeks before any surgical procedure.
Pregnancy and breastfeeding. Avoid Bacopa during pregnancy and while breastfeeding due to insufficient safety data.
GI sensitivity. The most common side effects are loose stools, nausea, and mild stomach cramps. Taking Bacopa with food reduces these significantly. Starting at a lower dose and building up over 2 to 4 weeks also helps.
Bacopa Alongside Standard ADHD Treatment: What Doctors Say
Bacopa is increasingly being considered as a complementary support alongside standard ADHD care, not as a standalone replacement.
For children already on prescribed ADHD medication, Bacopa may be considered for additional cognitive support, but only in consultation with the treating paediatrician or child psychiatrist. The interaction profile discussed above must be reviewed in the context of any existing medication.
For children and adults not currently on medication, or those in whom medication is not effective or not tolerated, Bacopa represents one of the better-studied herbal options with a meaningful, if modest, evidence base.
The key distinction: Bacopa is not going to produce the dramatic, fast-acting symptom relief of stimulant medications. What it may offer, over consistent use, is a gradual improvement in attention, working memory, and impulse control, with significantly fewer side effects and a very different risk profile.
You can read more about how Brahmi works at a biological level in our full guide: Science-Backed Benefits of Bacopa Monnieri (Brahmi).
What Else Supports Focus and Attention in ADHD
Bacopa works best as part of a broader approach. The following consistently support attention and cognitive function in both children and adults with ADHD:
Sleep. Non-negotiable. Insufficient or disrupted sleep worsens every ADHD symptom significantly. Consistent sleep and wake times are foundational.
Physical movement. Exercise is one of the most studied non-pharmacological interventions for ADHD. Even 20 to 30 minutes of aerobic activity daily has measurable effects on dopamine and norepinephrine - the same neurotransmitters targeted by stimulant medications.
Reduced screen time. Especially relevant for children. High screen exposure mimics and worsens the attentional fragmentation that characterises ADHD.
Structured routine. Predictable daily structure reduces the cognitive load on the prefrontal cortex, freeing up capacity for sustained attention.
Nutrition. Iron deficiency, B12 deficiency, and low omega-3 intake all worsen inattention and are common in Indian children's diets. Getting these assessed is worthwhile.
If focus and mental fog are part of the picture beyond ADHD, our guide on what brain fog is and what causes it covers the nutritional and lifestyle drivers in more detail.
A Summary: Bacopa Dosage for ADHD at a Glance
|
Who |
Dosage |
Form |
Minimum Duration |
|---|---|---|---|
|
Children 6 – 8 years |
100 to 150mg/day standardised extract |
Liquid drops in warm milk |
12 weeks |
|
Children 9 – 12 years |
150 to 225mg/day standardised extract |
Liquid drops or child capsule |
12 weeks |
|
Teens 13 – 18 years |
225 to 300mg/day standardised extract |
Liquid drops or capsule |
12 weeks |
|
Adults |
300 to 450mg/day standardised extract |
Capsule with food |
12 weeks minimum |
Always start at the lower end of the range. Always take with food. Always consult a doctor if any other medication is involved.
The Bottom Line
Bacopa Monnieri has a meaningful, if still growing, research record for ADHD-related symptoms - particularly in children. The Mumbai open-label trial is the most cited, and its results were notable for a herbal intervention.
It is not a replacement for proper ADHD diagnosis and treatment. It will not work in two weeks. And it is not appropriate for everyone without checking drug interactions first.
But for families looking for a well-studied, clean-profile herbal supplement to support attention and cognitive function, Brahmi remains one of the most substantiated options in India's traditional and modern pharmacopoeia.
BACOMAX by MB Vitals: Brahmi for Adults and Children
For adults: MB Vitals BACOMAX is formulated with standardised Bacopa Monnieri extract alongside Ashwagandha, Shankhpushpi, Gotu Kola, and Ginkgo Biloba - a multi-herb blend designed to support memory, focus, stress resilience, and mental clarity. Available in veg capsules for daily use.
For children: MB Vitals BACOMAX Drops is a liquid drop formulation built specifically for school-age children and teenagers. Standardised Bacopa extract in a child-appropriate dose, easy to mix into warm milk, free from artificial additives and manufactured under GMP-certified standards.
Related Reading:
- Science-Backed Benefits of Bacopa Monnieri (Brahmi)
- Brahmi for Kids: Benefits, Dosage and Best Ways to Use
- What Is Brain Fog? Causes, Signs, and Simple Ways to Clear It
Disclaimer: This article is for informational and educational purposes only. Bacopa Monnieri is a herbal supplement, not a medicine, and is not intended to diagnose, treat, cure, or prevent ADHD or any other medical condition. Always consult a qualified doctor or paediatrician before starting any supplement, especially if your child is on prescribed ADHD medication or any other drug.
References
- Attention-Deficit/Hyperactivity Disorder (ADHD). https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
- Burden of Attention Deficit Hyperactivity Disorder (ADHD) in Indian Children: A Systematic Review and Meta-Analysis. https://pubmed.ncbi.nlm.nih.gov/35034274/
- An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children. https://pubmed.ncbi.nlm.nih.gov/24682000/
- An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children. https://pubmed.ncbi.nlm.nih.gov/24682000/
- Bacopa monnieri Eric A. Walker; Mark V. Pellegrini.. https://www.ncbi.nlm.nih.gov/books/NBK589635/
- Bacopa monnieri Eric A. Walker; Mark V. Pellegrini.. https://www.ncbi.nlm.nih.gov/books/NBK589635/